Skip to main content
SpringerLink
Log in

A review of neuroblastoma image-defined risk factors on magnetic resonance imaging

  • Pediatric Body MRI
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Neuroblastoma is the most common extracranial solid malignancy in children. Historically, neuroblastoma has been staged using the International Neuroblastoma Staging System (INSS), which relies on surgical staging. This is problematic because surgical resection can vary among surgeons and tumors and occurs at interval times from diagnosis. In 2009 the International Neuroblastoma Risk Group (INRG) created a new staging system that relies on preoperative imaging for staging. The INRG staging system consists of 20 image-defined risk factors (IDRF) across multiple organ systems, which help predict surgical outcomes/adequacy of resection and can be combined with clinical data to provide up-front risk stratification. The purpose of this review is to describe both the INSS and INRG staging systems and their limitations and to illustrate the definitions and IDRFs that comprise the INRG staging system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Mehta K, Haller JO, Legasto AC (2003) Imaging neuroblastoma in children. Crit Rev Comput Tomogr 44:47–61

    Article  PubMed  Google Scholar 

  2. Alvi S, Karadaghy O, Manalang M, Weatherly R (2017) Clinical manifestations of neuroblastoma with head and neck involvement in children. Int J Pediatr Otorhinolaryngol 97:157–162

    Article  PubMed  Google Scholar 

  3. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL (2002) Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22:911–934

    Article  PubMed  Google Scholar 

  4. Chu CM, Rasalkar DD, Hu YJ et al (2011) Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm. Br J Radiol 84:81–91

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Nour-Eldin NE, Abdelmonem O, Tawfik AM et al (2012) Pediatric primary and metastatic neuroblastoma: MRI findings: pictorial review. Magn Reson Imaging 30:893–906

  6. Brisse HJ, McCarville MB, Granata C et al (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group project. Radiology 261:243–257

  7. D'Ambrosio N, Lyo JK, Young RJ et al (2010) Imaging of metastatic CNS neuroblastoma. AJR Am J Roentgenol 194:1223–1229

    Article  PubMed  Google Scholar 

  8. Cistaro A, Quartuccio N, Caobelli F et al (2015) 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma. Nucl Med Rev Cent East Eur 18:102–106

    Article  PubMed  Google Scholar 

  9. Sharp SE, Gelfand MJ, Shulkin BL (2008) PET/CT in the evaluation of neuroblastoma. PET Clin 3:551–561

    Article  PubMed  Google Scholar 

  10. Sharp SE, Gelfand MJ, Shulkin BL (2011) Pediatrics: diagnosis of neuroblastoma. Semin Nucl Med 41:345–353

    Article  PubMed  Google Scholar 

  11. Cohn SL, Pearson AD, London WB et al (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289–297

  12. Bishop MW, Yin H, Shimada H et al (2014) Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule. J Pediatr Hematol Oncol 36:e31–e35

    Article  PubMed  Google Scholar 

  13. Matthay KK, Shulkin B, Ladenstein R et al (2010) Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) task force. Br J Cancer 102:1319–1326

  14. Sharp SE, Shulkin BL, Gelfand MJ et al (2009) 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med 50:1237–1243

    Article  PubMed  Google Scholar 

  15. Siegel MJ, Ishwaran H, Fletcher BD et al (2002) Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology 223:168–175

    Article  PubMed  Google Scholar 

  16. Padhani AR, Liu G, Mu-Koh D et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Serin HI, Gorkem SB, Doganay S et al (2016) Diffusion weighted imaging in differentiating malignant and benign neuroblastic tumors. Jpn J Radiol 34:620–624

    Article  PubMed  CAS  Google Scholar 

  18. Wen Y, Peng Y, Duan XM, Zhang N (2017) Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades. J Med Imaging Radiat Oncol 61:718–724

    Article  PubMed  Google Scholar 

  19. Neubauer H, Li M, Muller VR et al (2017) Diagnostic value of diffusion-weighted MRI for tumor characterization, differentiation and monitoring in pediatric patients with neuroblastic tumors. RöFo 189:640–650

    PubMed  Google Scholar 

  20. Simon T, Hero B, Benz-Bohm G et al (2008) Review of image defined risk factors in localized neuroblastoma patients: results of the GPOH NB97 trial. Pediatr Blood Cancer 50:965–969

    Article  PubMed  Google Scholar 

  21. Monclair T, Brodeur GM, Ambros PF et al (2009) The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298–303

    Article  PubMed  PubMed Central  Google Scholar 

  22. Shamberger RC, Smith EI, Joshi VV et al (1998) The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg 33:161–164

    Article  PubMed  CAS  Google Scholar 

  23. Sharp SE, Trout AT, Weiss BD, Gelfand MJ (2016) MIBG in neuroblastoma diagnostic imaging and therapy. Radiographics 36:258–278

    Article  PubMed  Google Scholar 

  24. Demir HA, Yalcin B, Buyukpamukcu N et al (2010) Thoracic neuroblastic tumors in childhood. Pediatr Blood Cancer 54:885–889

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Cincinnati Children’s Hospital, 3333 Burnet Ave., MLC 5031, Cincinnati, OH, 45229, USA

    Alan M. Chen, Andrew T. Trout & Alexander J. Towbin

Authors
  1. Alan M. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew T. Trout
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander J. Towbin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander J. Towbin.

Ethics declarations

Conflicts of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, A.M., Trout, A.T. & Towbin, A.J. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatr Radiol 48, 1337–1347 (2018). https://doi.org/10.1007/s00247-018-4117-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-018-4117-9

Keywords

Search

Navigation